Furthermore, our data suggest that deletion of the MR in EC during baseline and in conditions of hypertension and endothelial dysfunction does not affect overall acetylcholine-induced endothelium dependent responses, and likely the bioavailability of NO in renal arteries. The gene discussed is NR3C2; the disease is endothelial dysfunction.